Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Free Trial Request
Subscribe
Advertising
UsernamePublicRestriction
Tags:
Consumer BioPharmaceutical United States

Umbrella Branding Is ‘Particular Concern’ As FDA Requests Research Proposals

This article was originally published in The Tan Sheet

  • News

Executive Summary

FDA seeks research proposals to evaluate consumers’ understanding of OTC drugs bearing umbrella brand names. The agency says the data also will benefit regulatory action and future guidance development as well as provide knowledge to scientists studying risk communication of drugs.

Table

View full table

Advertisement

Related Content

Pink Sheet
OTC Umbrella Branding Soaked By Regulatory Storm In Draft Guidance – CHPA
Pink Sheet
Draft Guidance On Developing Drug Names Calls For Simulation Studies

Topics

What to read next

Advertisement
Tags:
Consumer BioPharmaceutical United States
UsernamePublicRestriction

Register

PS107830

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By